Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs ElixaMD

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and ElixaMD head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 280 · Grade C

ElixaMD

Visit ElixaMD Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 64 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make ElixaMD a bad call — it's best for readers comparing compounded and branded pathways who will confirm medication costs and any membership charge separately. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
36
Supply Reliability
95
76
Transparency
90
72
Access Breadth
93
40
Clinical Oversight
92
95
Track Record
88
78
CoreAge RxBrief Score 94 · 64ElixaMD

Price, coverage & the tracker

CoreAge RxElixaMD
Brief Score94/100 (A)64/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

From $179/mo (starting dose, first-month rate, compounded)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Not disclosed

CoverageUS only; restrictions by state, confirmed at intakeCoverage not published
Brand-name accessNot confirmedYes
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

ElixaMD: Branded options advertise a $99 membership charge plus medication. The older $179 compounded introductory figure has not been reverified; obtain a current first-payment and renewal quote.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.